BCIC Ecosystem | BCIC Award-Winning Team Affinity Biopharma Raises 400 Million CNY
Congratulations to Affinity Biopharma for raising 400 milllion CNY ( ~$60 million) , successfully in its series B2 financing round. Affinity Biopharma was awarded with Second Prize award in 2024 Biomedical Pitch Competition organized by Boston Chinese Investment Club (BCIC) and Hong Kong Science and Technology Parks Corporation (HKSTP)
http://www.affinitybiopharma.com/en/newsD-543.html
2024 Biomedical Pitch Competition Final
First Prize
GV20 Therapeutics
Second Prize
Affinity Biopharma
Axcynsis Therapeutics
Third Prize
ImmVira Group: A Novel Payload Deliver
Rapafusyn Pharmaceuticals
Cure Genetics Inc.
D2M Biotherapeutics
Innovation Award
Leveragen, Inc.
f5 Therapeutics Incorporated
Agilis Robotics Limited
Spark Spine
Azura Bio, Inc.
AI-powered Painless Blood Test Device
NeuronOff, Inc.